Various
Analyst Upgrades and Downgrades For the Week of August 12th
Analyst upgrades, downgrades, and more
By Justin Nugent · August 12, 2024

August 16th Upgrades, Downgrades, and More
Upgrades – Friday, August 16, 2024
- AFC Gamma (AFCG)
- Brokerage Firm: Compass Point
- Ratings Change: Sell >> Neutral
- Price Target: $10 >> $9
- CF Industries (CF)
- Brokerage Firm: Barclays
- Ratings Change: Equal Weight >> Overweight
- Price Target: $80 >> $90
- Cisco (CSCO)
- Brokerage Firm: HSBC Securities
- Ratings Change: Hold >> Buy
- Price Target: $46 >> $58
- Fox Corporation (FOXA)
- Brokerage Firm: Wells Fargo
- Ratings Change: Underweight >> Overweight
- Price Target: $29 >> $46
- Illumina (ILMN)
- Brokerage Firm: Daiwa Securities
- Ratings Change: Neutral >> Buy
- Price Target: $120 >> $154
- Kimco Realty (KIM)
- Brokerage Firm: Raymond James
- Ratings Change: Market Perform >> Strong Buy
- Price Target: $25
- Kite Realty (KRG)
- Brokerage Firm: Raymond James
- Ratings Change: Market Perform >> Strong Buy
- Price Target: $28
- Microchip (MCHP)
- Brokerage Firm: Piper Sandler
- Ratings Change: Neutral >> Overweight
- Price Target: $90 >> $100
- Newmark Group (NMRK)
- Brokerage Firm: Wolfe Research
- Ratings Change: Peer Perform >> Outperform
- Price Target: $15
- Sphere Entertainment Co. (SPHR)
- Brokerage Firm: JP Morgan
- Ratings Change: Neutral >> Overweight
- Price Target: $37 >> $57
- Teradyne (TER)
- Brokerage Firm: Cantor Fitzgerald
- Ratings Change: Neutral >> Overweight
- Price Target: $16
- Origin Materials (ORGN)
- Brokerage Firm: BofA Securities
- Ratings Change: Neutral >> Buy
- Price Target: $1.35 >> $3
- EnLink Midstream (ENLC)
- Brokerage Firm: Tudor, Pickering, Holt & Co.
- Ratings Change: Hold >> Buy
- Price Target: $15
- JD.com (JD)
- Brokerage Firm: JP Morgan
- Ratings Change: Neutral >> Overweight
- Price Target: $33 >> $36
- Alnylam Pharma (ALNY)
- Brokerage Firm: Goldman
- Ratings Change: Neutral >> Buy
- Price Target: $198 >> $370
- CI&T Inc (CINT)
- Brokerage Firm: Itau BBA
- Ratings Change: Market Perform >> Outperform
Downgrades – Friday, August 16, 2024
- Bumble Inc. (BMBL)
- Brokerage Firm: TD Cowen
- Ratings Change: Buy >> Hold
- Price Target: $22 >> $7.5
- CAE (CAE)
- Brokerage Firm: Morgan Stanley
- Ratings Change: Overweight >> Equal-Weight
- Coherus BioSciences (CHRS)
- Brokerage Firm: UBS
- Ratings Change: Buy >> Neutral
- Price Target: $4 >> $1.5
- Estee Lauder (EL)
- Brokerage Firm: BofA Securities
- Ratings Change: Buy >> Neutral
- Price Target: $140 >> $100
- Lumen Technologies (LUMN)
- Brokerage Firm: Wells Fargo
- Ratings Change: Equal Weight >> Underweight
- Price Target: $1.75 >> $4
- Silicon Motion (SIMO)
- Brokerage Firm: BofA Securities
- Ratings Change: Buy >> Underperform
- Price Target: $90 >> $60
- Viracta Therapeutics (VIRX)
- Brokerage Firm: Leerink Partners
- Ratings Change: Outperform >> Market Perform
- Price Target: $5 >> $3
- Vital Energy (VTLE)
- Brokerage Firm: KeyBanc Capital Markets
- Ratings Change: Overweight >> Sector Weight
- Xos (XOS)
- Brokerage Firm: DA Davidson
- Ratings Change: Buy >> Neutral
- Price Target: $17 >> $9
- Cardlytics (CDLX)
- Brokerage Firm: Northland Capital
- Ratings Change: Outperform >> Market Perform
- Price Target: $5
Coverage Initiated – Friday, August 16, 2024
- Couchbase (BASE)
- Brokerage Firm: Piper Sandler
- Ratings Change: Overweight
- Price Target: $22
- Liquidia Technologies (LQDA)
- Brokerage Firm: Raymond James
- Ratings Change: Outperform
- Price Target: $27
- Y-mAbs Therapeutics (YMAB)
- Brokerage Firm: Cantor Fitzgerald
- Ratings Change: Overweight
- Price Target: $20
- Two Harbors Investment (TWO)
- Brokerage Firm: Janney
- Ratings Change: Buy
- Price Target: $15
August 15th Upgrades, Downgrades, and More
Upgrades:
- Dutch Bros (BROS): UBS upgraded from Neutral to Buy; Price Target: $39.
- Brinker (EAT): KeyBanc Capital Markets upgraded from Sector Weight to Overweight; Price Target: $72.
- Robinhood Markets (HOOD): Deutsche Bank upgraded from Hold to Buy; Price Target increased from $21 to $24.
- Medtronic (MDT): UBS upgraded from Sell to Neutral; Price Target increased from $76 to $90.
- Progressive (PGR): Goldman upgraded from Neutral to Buy; Price Target increased from $230 to $262.
Downgrades:
- Snowflake (SNOW): Wells Fargo downgraded from Overweight to Equal Weight; Price Target decreased from $200 to $130.
- Las Vegas Sands (LVS): Argus downgraded from Buy to Hold.
- Pilgrim’s Pride (PPC): BofA Securities downgraded from Buy to Neutral; Price Target: $47.
- Bluebirdbio (BLUE): JP Morgan downgraded from Overweight to Neutral.
Coverage Initiated:
- Advanced Energy (AEIS): Stifel initiated coverage with a Buy rating; Price Target: $135.
- Tyra Biosciences (TYRA): Piper Sandler initiated coverage with an Overweight rating; Price Target: $33.
- Valvoline (VVV): Robert W. Baird initiated coverage with an Outperform rating; Price Target: $48.
August 14th Upgrades, Downgrades, and More
Upgrades (August 14, 2024)
- American Woodmark (AMWD): Wolfe Research – Peer Perform >> Outperform, Price Target: $110
- Ball Corp (BALL): Robert W. Baird – Neutral >> Outperform, Price Target: $70
- Cidara Therapeutics (CDTX): H.C. Wainwright – Neutral >> Buy, Price Target: $24
- Chipotle Mexican Grill (CMG): Wedbush – Neutral >> Outperform, Price Target: $54 >> $58
- EQT Corp. (EQT): Wells Fargo – Equal Weight >> Overweight, Price Target: $40 >> $42
- Hudbay Minerals (HBM): Jefferies – Hold >> Buy
- HUYA (HUYA): Citigroup – Sell >> Buy, Price Target: $2.4 >> $6
- Illumina (ILMN):
- Barclays – Underweight >> Equal Weight, Price Target: $125
- TD Cowen – Hold >> Buy, Price Target: $126 >> $144
- Johnson Controls (JCI): RBC Capital Mkts – Underperform >> Sector Perform, Price Target: $61 >> $69
- L’Oreal (LRLCY): Jefferies – Underperform >> Hold
- Meritage (MTH): Wolfe Research – Peer Perform >> Outperform, Price Target: $230
- nCino (NCNO): Goldman – Neutral >> Buy, Price Target: $34 >> $42
- Nkarta (NKTX): Raymond James – Outperform >> Strong Buy, Price Target: $16
- Starbucks (SBUX):
- Evercore ISI – In-line >> Outperform, Price Target: $80 >> $120
- Deutsche Bank – Hold >> Buy, Price Target: $85 >> $118
- Stifel – Hold >> Buy, Price Target: $80 >> $110
- Sportradar Group AG (SRAD): Jefferies – Hold >> Buy, Price Target: $12 >> $16
- Int’l Paper (IP): Argus – Hold >> Buy, Price Target: $52
- Sea Limited (SE): JP Morgan – Neutral >> Overweight, Price Target: $66 >> $90
- Hut 8 Mining (HUT): H.C. Wainwright – Sell >> Buy, Price Target: $7.5 >> $13.5
- FLEX LNG (FLNG): Jefferies – Underperform >> Hold, Price Target: $24
- Lithium Argentina (LAAC): HSBC Securities – Hold >> Buy
- Victoria’s Secret (VSCO): Morgan Stanley – Underweight >> Equal-Weight
Downgrades (August 14, 2024)
- Emerson (EMR): JP Morgan – Overweight >> Neutral, Price Target: $132 >> $115
- Hudson Pacific Properties (HPP): Wolfe Research – Outperform >> Peer Perform
- Hershey Foods (HSY): Argus – Buy >> Hold
- Hexcel (HXL): RBC Capital Mkts – Outperform >> Sector Perform, Price Target: $76 >> $68
- Intuit (INTU): Morgan Stanley – Overweight >> Equal-Weight, Price Target: $750 >> $685
- L3Harris (LHX): RBC Capital Mkts – Outperform >> Sector Perform, Price Target: $250 >> $240
- Medtronic (MDT): Stifel – Buy >> Hold, Price Target: $100 >> $85
- Marinus Pharmaceuticals (MRNS): Ladenburg Thalmann – Buy >> Neutral
- Ranpak (PACK): Robert W. Baird – Outperform >> Neutral, Price Target: $10
- PulteGroup (PHM): Wolfe Research – Outperform >> Peer Perform
- Playa Hotels & Resorts (PLYA): Citigroup – Buy >> Neutral, Price Target: $12 >> $8
- ACELYRIN (SLRN): H.C. Wainwright – Buy >> Neutral, Price Target: $18 >> $6
- IDEX Corp (IEX): Argus – Buy >> Hold
Coverage Initiated (August 14, 2024)
- DTE Energy (DTE): Ladenburg Thalmann – Buy, Price Target: $131
- Enova International (ENVA): BTIG Research – Buy, Price Target: $90
- Korro Bio (KRRO): William Blair – Outperform, Price Target: $180
- Montrose Environmental Group (MEG): Evercore ISI – Outperform, Price Target: $43
- VSE Corp (VSEC): Jefferies – Buy, Price Target: $100
- First Solar (FSLR): Clarksons Platou – Buy, Price Target: $270
August 12th Upgrades, Downgrades, and More
Upgrades:
- Allstate (ALL): Wells Fargo upgraded from Underweight to Equal Weight; price target increased from $142 to $177.
- Blend Labs (BLND): Canaccord Genuity upgraded from Hold to Buy; price target raised from $3 to $4.75.
- Brown & Brown (BRO): Wells Fargo upgraded from Equal Weight to Overweight; price target increased from $94 to $112.
- Churchill Downs (CHDN): BofA Securities upgraded from Neutral to Buy; price target raised from $145 to $155.
- Diageo plc (DEO): RBC Capital Markets upgraded from Underperform to Sector Perform.
- Goldman Sachs BDC (GSBD): Wells Fargo upgraded from Underweight to Equal Weight; price target adjusted from $14 to $12.
- Robinhood Markets (HOOD): Piper Sandler upgraded from Neutral to Overweight; price target raised from $20 to $23.
- Liberty Global (LBTYA): BofA Securities upgraded from Underperform to Neutral; price target raised from $15.5 to $21.3.
- Camden Property (CPT): BofA Securities upgraded from Underperform to Buy; price target increased from $111 to $147.
- Eli Lilly (LLY): Deutsche Bank upgraded from Hold to Buy; price target set at $1025.
- Mid-America Apartment (MAA): BofA Securities upgraded from Underperform to Buy; price target raised from $144 to $189.
- PAR Technology (PAR): Jefferies upgraded from Hold to Buy; price target increased from $45 to $60.
- Prudential (PRU): Wells Fargo upgraded from Underweight to Equal Weight; no price target provided.
- Take-Two (TTWO): HSBC Securities upgraded from Hold to Buy; price target set at $179.
- Zentalis Pharma (ZNTL): Wedbush upgraded from Underperform to Neutral; price target set at $4.
- Power Integrations (POWI): Northland Capital upgraded from Market Perform to Outperform; price target set at $80.
- Progressive (PGR): HSBC Securities upgraded from Hold to Buy; price target set at $253.
- Coherent (COHR): BofA Securities upgraded from Neutral to Buy; price target raised from $65 to $75.
- PennantPark Floating Rate Capital (PFLT): Maxim Group upgraded from Hold to Buy; price target set at $12.
- CBIZ (CBZ): Sidoti upgraded from Neutral to Buy; price target increased from $80 to $86.
- Alcoa (AA): UBS upgraded from Sell to Buy; price target raised from $32 to $38.
Downgrades:
- Algonquin Power & Utilities (AQN): Wells Fargo downgraded from Overweight to Equal Weight; price target reduced from $8.5 to $6.
- Brighthouse Financial (BHF): Wells Fargo downgraded from Equal Weight to Underweight; price target reduced from $51 to $40.
- Bank of Hawaii (BOH): Piper Sandler downgraded from Neutral to Underweight; price target reduced from $70 to $61.
- Hillenbrand (HI): DA Davidson downgraded from Buy to Neutral; price target reduced from $54 to $33.
- Janus International Group (JBI): Wolfe Research downgraded from Outperform to Peer Perform.
- Lion Electric (LEV): DA Davidson downgraded from Buy to Neutral; price target reduced from $1.5 to $1.
- Pacira BioSciences (PCRX): Multiple downgrades:
- RBC Capital Markets from Outperform to Sector Perform; price target reduced from $37 to $14.
- Raymond James from Outperform to Market Perform.
- JP Morgan from Overweight to Underweight; price target reduced from $45 to $10.
- Piper Sandler from Overweight to Neutral; price target reduced from $42 to $11.
- Prologis (PLD): BofA Securities downgraded from Buy to Neutral; no new price target.
- Piedmont Lithium (PLL): Macquarie downgraded from Outperform to Neutral; price target adjusted from $9.3.
- Pilgrim’s Pride (PPC): BMO Capital Markets downgraded from Outperform to Market Perform; price target reduced from $46.
- Qualcomm (QCOM): Wolfe Research downgraded from Outperform to Peer Perform.
- EchoStar (SATS): JP Morgan downgraded from Neutral to Underweight; price target set at $12.
- Sylvamo (SLVM): BofA Securities downgraded from Buy to Neutral; price target reduced from $71 to $82.
- Triumph Group (TGI): Jefferies downgraded from Buy to Hold; price target reduced from $20 to $14.
- Algonquin Power & Utilities (AQN): Raymond James downgraded from Outperform to Market Perform.
- Gladstone Land (LAND): Maxim Group downgraded from Buy to Hold.
- Ballard Power (BLDP): TD Securities downgraded from Hold to Sell.
Coverage Initiated:
- Arcturus Therapeutics (ARCT): Leerink Partners initiated coverage with an Outperform rating; price target set at $70.
- Ardent Health Partners (ARDT): Multiple firms initiated coverage with varying ratings:
- Truist: Buy, $21
- Leerink Partners: Outperform, $23
- Mizuho: Outperform, $20
- JP Morgan: Neutral, $18
- Morgan Stanley: Overweight, $27
- RBC Capital Markets: Outperform, $23
- Citigroup: Buy, $21
- Stephens: Overweight, $24
- BofA Securities: Buy, $22
- Loop Capital: Buy, $18
- Conagra (CAG): Goldman initiated coverage with a Buy rating; price target set at $36.
- Hershey Foods (HSY): Goldman initiated coverage with a Sell rating; price target set at $185.
- J. Jill (JILL): TD Cowen initiated coverage with a Hold rating; price target set at $37.
- Kellanova (K): Goldman initiated coverage with a Neutral rating; price target set at $75.
- Kraft Heinz (KHC): Goldman initiated coverage with a Sell rating; price target set at $34.
- LENZ Therapeutics (LENZ): H.C. Wainwright initiated coverage with a Buy rating; price target set at $38.
- Summit Therapeutics (SMMT): H.C. Wainwright initiated coverage with a Buy rating; price target set at $16.
- Solaris Resources Inc. (SLSR): H.C. Wainwright initiated coverage with a Buy rating; price target set at $10.
- USCB Financial Holdings (USCB): Hovde Group initiated coverage with a Market Perform rating; price target set at $16.
- Dave, Inc. (DAVE): The Benchmark Company initiated coverage with a Buy rating; price target set at $53.
- GE Vernova (GEV): HSBC Securities initiated coverage with a Buy rating; price target set at $215.
- General Mills (GIS): Goldman initiated coverage with a Buy rating; price target set at $76.
- Mondelez International (MDLZ): Goldman initiated coverage with a Buy rating; price target set at $80.
- Morningstar (MORN): BMO Capital Markets initiated coverage with an Outperform rating; price target set at $352.
- Tempus AI (TEM): Piper Sandler initiated coverage with a Neutral rating; price target set at $40.
- TWFG, Inc. (TWFG): Multiple firms initiated coverage with varying ratings:
- Keefe Bruyette: Market Perform, $27
- UBS: Buy, $29
- RBC Capital Markets: Outperform, $29
- JP Morgan: Overweight, $26.5
- Piper Sandler: Overweight, $27
- Morgan Stanley: Equal-Weight, $23
- BMO Capital Markets: Outperform, $30
- GDEV Inc. (GDEV): Noble Capital Markets initiated coverage with an Outperform rating; price target set at $6.
